These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 10646653)
1. Homocysteine, hypothyroidism, and effect of thyroid hormone replacement. Catargi B; Parrot-Roulaud F; Cochet C; Ducassou D; Roger P; Tabarin A Thyroid; 1999 Dec; 9(12):1163-6. PubMed ID: 10646653 [TBL] [Abstract][Full Text] [Related]
2. Normalization of hyperhomocysteinemia with L-thyroxine in hypothyroidism. Hussein WI; Green R; Jacobsen DW; Faiman C Ann Intern Med; 1999 Sep; 131(5):348-51. PubMed ID: 10475887 [TBL] [Abstract][Full Text] [Related]
3. Elevated Homocysteine Levels Are Associated With the Metabolic Syndrome and Cardiovascular Events in Hypertensive Patients. Catena C; Colussi G; Nait F; Capobianco F; Sechi LA Am J Hypertens; 2015 Jul; 28(7):943-50. PubMed ID: 25498997 [TBL] [Abstract][Full Text] [Related]
7. Homocysteine: a risk factor for cardiovascular disease in subclinical hypothyroidism? Deicher R; Vierhapper H Thyroid; 2002 Aug; 12(8):733-6. PubMed ID: 12225643 [TBL] [Abstract][Full Text] [Related]
8. Serum homocysteine concentrations in children with growth hormone (GH) deficiency before and after 12 months GH replacement. Esposito V; Di Biase S; Lettiero T; Labella D; Simeone R; Salerno M Clin Endocrinol (Oxf); 2004 Nov; 61(5):607-11. PubMed ID: 15521964 [TBL] [Abstract][Full Text] [Related]
9. Homocysteine, folate and cobalamin levels in hypothyroid women before and after treatment. Orzechowska-Pawilojc A; Sworczak K; Lewczuk A; Babinska A Endocr J; 2007 Jun; 54(3):471-6. PubMed ID: 17464093 [TBL] [Abstract][Full Text] [Related]
10. Effect of thyroid hormone replacement on methionine-stimulated homocysteine levels in patients with subclinical hypothyroidism: a randomized, double-blind, placebo-controlled study. Meek S; Smallridge RC Endocr Pract; 2006; 12(5):529-34. PubMed ID: 17002927 [TBL] [Abstract][Full Text] [Related]
11. Comparative study of response to treatment with supraphysiologic doses of B-vitamins in hyperhomocysteinemic hemodialysis patients. Nakhoul F; Abassi Z; Plawner M; Khankin E; Ramadan R; Lanir N; Brenner B; Green J Isr Med Assoc J; 2004 Apr; 6(4):213-7. PubMed ID: 15115259 [TBL] [Abstract][Full Text] [Related]
12. Mild hyperhomocysteinemia and low folate concentrations as risk factors for cervical arterial dissection. Arauz A; Hoyos L; Cantú C; Jara A; Martínez L; García I; Fernández Mde L; Alonso E Cerebrovasc Dis; 2007; 24(2-3):210-4. PubMed ID: 17596690 [TBL] [Abstract][Full Text] [Related]
13. Serum homocysteine, folate, vitamin B12 levels and arterial stiffness in diabetic patients: which of them is really important in atherogenesis? Shargorodsky M; Boaz M; Pasternak S; Hanah R; Matas Z; Fux A; Beigel Y; Mashavi M Diabetes Metab Res Rev; 2009 Jan; 25(1):70-5. PubMed ID: 19065546 [TBL] [Abstract][Full Text] [Related]
14. Impact of subclinical hypothyroidism on serum total homocysteine concentrations, the prevalence of coronary heart disease (CHD), and CHD risk factors in the New Mexico Elder Health Survey. Lindeman RD; Romero LJ; Schade DS; Wayne S; Baumgartner RN; Garry PJ Thyroid; 2003 Jun; 13(6):595-600. PubMed ID: 12930604 [TBL] [Abstract][Full Text] [Related]
15. Hyperhomocysteinemia as a cardiovascular risk factor in Indian women: determinants and directionality. Pandey SN; Vaidya AD; Vaidya RA; Talwalkar S J Assoc Physicians India; 2006 Oct; 54():769-74. PubMed ID: 17214272 [TBL] [Abstract][Full Text] [Related]
16. Risk factors for cardiovascular disease in women with subclinical hypothyroidism. Luboshitzky R; Aviv A; Herer P; Lavie L Thyroid; 2002 May; 12(5):421-5. PubMed ID: 12097204 [TBL] [Abstract][Full Text] [Related]
17. Thyrotropin suppression by thyroid hormone replacement is correlated with thyroxine level normalization in central hypothyroidism. Shimon I; Cohen O; Lubetsky A; Olchovsky D Thyroid; 2002 Sep; 12(9):823-7. PubMed ID: 12481949 [TBL] [Abstract][Full Text] [Related]
18. A study on serum homocysteine and oxidized LDL as markers of cardiovascular risk in patients with overt hypothyroidism. Kumar Singh N; Suri A; Kumari M; Kaushik P Horm Mol Biol Clin Investig; 2022 Sep; 43(3):329-335. PubMed ID: 35179003 [TBL] [Abstract][Full Text] [Related]
19. Which thyroid-stimulating hormone level should be sought in hypothyroid patients under L-thyroxine replacement therapy? Gursoy A; Ozduman Cin M; Kamel N; Gullu S Int J Clin Pract; 2006 Jun; 60(6):655-9. PubMed ID: 16805747 [TBL] [Abstract][Full Text] [Related]